Navigation Links
New Blood Thinner Beats Older Drug for Vein Clots: Study
Date:2/20/2013

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Feb. 20 (HealthDay News) -- People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, researchers report.

Long-term treatment of these blood clots is safer and more convenient with Pradaxa than warfarin, the new study found.

Extended treatment with blood thinners after clots develop in the veins or the lungs should be considered more often than it is, said lead researcher Dr. Sam Schulman, a professor in the division of hematology and thromboembolism at McMaster University in Hamilton, Ontario, Canada.

If a clot in the leg breaks loose and travels to the heart, brain or lungs, it can cause a heart attack, stroke or a pulmonary embolism -- all of which can be fatal.

People taking warfarin need periodic blood tests to be sure they aren't getting too much of the drug, which raises the risk of major bleeding, or too little, which is ineffective.

Pradaxa also has a lower risk of bleeding than warfarin, Schulman said, and the bleeding that does occur is less serious than that seen with warfarin, he added.

For the study, published Feb. 21 in the New England Journal of Medicine, Schulman's team conducted two studies of more than 2,800 patients, average age 56, who had clots in the legs, also known as venous thromboembolism. In one, Pradaxa was compared with warfarin, and in the other Pradaxa was compared with placebo.

In the Pradaxa-warfarin comparison, the researchers found that 1.8 percent of patients taking Pradaxa had recurrent clots, compared with 1.3 percent of patients taking warfarin. Fewer patients taking Pradaxa, however, had major bleeding (13) compared with those taking warfarin (25).

In the study comparing Pradaxa with a placebo, three patients taking the drug developed clots, compared wit
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Children’s Cancer & Blood Foundation to Host Private Party at American Girl Place, New York City
2. Damage to Tiny Blood Vessels in Brain May Raise Alzheimers Risk
3. NuvaRing Lawsuit Filed on Behalf of a South Carolina Woman who Developed Two Blood Clots While Using NuvaRing, Reports Wright & Schulte LLC
4. US Drug Watchdog Now Urges All DePuy ASR And Pinnacle All Metal Hip Implant Recipients To Get A Blood Test And To Call Them Before The Time Runs Out To Get Identified
5. STEMSOFT and The Canadian Blood and Marrow Transplant Group Announce Partnership
6. High Blood Pressure in Pregnancy May Predict Later Ills, Study Says
7. NuvaRing Blood-Clotting Victims Still Eligible to File Lawsuits Through Resource4thePeople
8. Blood-based test detects cancer earlier, from the February 2013 Harvard Health Letter
9. Scientists discover protein that allows safe recycling of iron from old red blood cells
10. US Drug Watchdog Now Urges All DePuy ASR and Pinnacle Hip Implant Recipients to Get a Blood Test for Metals Levels and to Call Them for the Names of the Best Law Firms
11. Rock River Valley Blood Center offering Pint of Culver’s Frozen Custard to Donors in February
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Blood Thinner Beats Older Drug for Vein Clots: Study
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... healthcare services programs, the organization has hired two new ... Ph.D. They will report to Grace Pavlath, Ph.D, ... President and Scientific Program Director, and together will lead ... to treatments and cures for various types of neuromuscular ...
(Date:3/6/2015)... San Rafael, CA (PRWEB) March 06, 2015 ... the addition of three Maryland camps – two non-contact ... camps will be run by Perfect Performance Training, located ... camps will focus on developing position specific skills, speed ... will be hosted at Salisbury University with Marvin Graves, ...
(Date:3/6/2015)... March 06, 2015 Johnson & Johnson ... verdict on March 5, 2015 in Superior Court in ... court documents, a jury of 12 awarded Mrs. Perry ... being implanted with an Ethicon TVT Abbrevo plastic sling ... and three women also awarded $5 million in punitive ...
(Date:3/6/2015)... GA (PRWEB) March 06, 2015 ... announced the release of a Clostridium Difficile (C ... providers. The C Diff use case is the ... that span hospital acquired infections, chronic conditions, and ... platform, the C Diff solution flags at risk ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 In a new ... Polish mesothelioma patients reported that shoulder pain was their first ... on its website. Click here to read it now. ... analyzed the medical records of 49 mesothelioma patients ... reported that it was shoulder pain that first prompted them ...
Breaking Medicine News(10 mins):Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2
... incentives tripled rates of cessation, study found, , , WEDNESDAY, Feb. ... to spur them to stop their unhealthy habit helps more ... published in the Feb. 12 issue of the New ... General Electric Co. employees across the country who were offered ...
... Inverness Medical Innovations, Inc. (NYSE: IMA ), ... announced that it will release its fourth quarter 2008 ... also host a conference call beginning at 10:00 a.m. ... and other corporate matters. During the conference call the ...
... Device To Aid Dentists & Doctors in Detecting Oral CancerGrowing ... Deadly Than Breast, Cervical, or Prostate Cancers , HOUSTON, Feb. ... aid in early detection, dentists, hygienists, and doctors have been ... oral cancer , ...
... 11 Teva Pharmaceuticals USA, the leading generic ... a nationwide campaign to push for more affordable ... Healthcare" commemorates the 25th anniversary of the landmark ... industry and has resulted in billions of dollars ...
... Service Corporation,International (NYSE: SCI ), which ... that its Board of Directors has approved a,quarterly cash ... The,quarterly cash dividend announced today is payable on ... of business on April 15, 2009. While the,Company ...
... Medical Institute researchers have identified a new biological marker ... that indicates whether the cancer is progressing and spreading. ... issue of the journal Nature, the scientists ... cells as cancer progresses. Their studies showed that one ...
Cached Medicine News:Health News:Promise of Cash Prompts Smokers to Quit 2Health News:Promise of Cash Prompts Smokers to Quit 3Health News:Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results 2Health News:New Identafi(TM) 3000 Identifies Signs of Silent Killer: 2Health News:New Identafi(TM) 3000 Identifies Signs of Silent Killer: 3Health News:New Identafi(TM) 3000 Identifies Signs of Silent Killer: 4Health News:Teva Launches National Advocacy Campaign for Affordable Healthcare 2Health News:Service Corporation International Declares Quarterly Cash Dividend 2Health News:Service Corporation International Declares Quarterly Cash Dividend 3Health News:Survey of metabolites finds new prostate cancer marker 2Health News:Survey of metabolites finds new prostate cancer marker 3
(Date:3/5/2015)... 5, 2015  As the pharmaceutical industry works ... & Compliance professionals are placing a significant emphasis ... issued today by LRN, the leader in Ethics ... majority of respondents expressed that clarity on company ... of E&C training programs (57%), trumping understanding of ...
(Date:3/5/2015)... ANDOVER, Mass. , March 5, 2015   ... pulmonary function testing (PFT) that employs precise ultrasound technology, ... free clinic event held by the San Antonio Pulmonary ... lung disease (ILD) or pulmonary fibrosis (PF), as well ... With a footprint of a mere 12 square ...
(Date:3/5/2015)... 2015  Celsion Corporation (NASDAQ: CLSN ... a conference call to discuss year-end 2014 financial ... programs for ThermoDox®, its proprietary heat-activated liposomal encapsulation ... TheraPlas™ and TheraSilence™, in immunotherapy and RNA delivery ... 2015. To participate in the call, interested parties ...
Breaking Medicine Technology:Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2
... Texas, Sept. 10 The first-ever human,clinical trial ... was,recently conducted, testing whether the tea can possibly ... trial also generated the first human safety data ... consumption of rooibos tea is safe for the ...
... - Abstracts 186 and 1003, Sanofi-aventis announced ... presented at the 44th annual meeting of the ... that a basal-bolus insulin,regimen with LANTUS(R) (insulin glargine ... APIDRA(R) (insulin glulisine [rDNA,origin] injection) at mealtime (bolus ...
Cached Medicine Technology:Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 2Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 3Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 4Clinical Trial Shows Cardiovascular Benefits of Rooibos, Popular Antioxidant Herbal Tea from South Africa 5Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 2Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 3Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: